A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:March 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorsLast Updated:March 12, 2024Recruiting
Condition(s):Advanced Solid TumorLast Updated:March 23, 2022Unknown status
Condition(s):Advanced Solid TumorsLast Updated:March 9, 2012Completed
Condition(s):Advanced Solid TumorLast Updated:May 1, 2023Recruiting
Condition(s):Advanced Solid TumorLast Updated:February 14, 2024Not yet recruiting
Condition(s):Advanced Solid Tumors; MelanomaLast Updated:October 12, 2022Completed
Condition(s):Advanced Solid TumorsLast Updated:January 14, 2013Completed
Condition(s):Patients With Advanced Solid TumorsLast Updated:May 11, 2022Not yet recruiting
Condition(s):Advanced Solid TumorsLast Updated:February 2, 2024Not yet recruiting
Condition(s):Advanced Solid TumorLast Updated:April 28, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.